Membranoproliferative GN II
Alternative names:
dense deposit disease; glomerulonephritis - membranoproliferative (type 2); membranoproliferative glomerulonephritis type 2; mesangiocapillary glomerulonephritis (type 2); MPGN2
Treatment:
Treatment may vary according to the symptoms. Treatment goals include reduction of symptoms, prevention of complications, and slowed progression of the disorder.
Dietary adjustments may include restrictions on sodium, fluids, protein, or other restrictions to control high blood pressure, swelling, and accumulation of waste products in the bloodstream.
Antihypertensive medications may be vital to help control blood pressure. Diuretics or other medications may be needed to control edema or other symptoms.
Dialysis or kidney transplantation may eventually be required to manage renal failure.
Expectations (prognosis):
The disorder progresses slowly to chronic renal failure. Fifty percent of cases will develop chronic renal failure within 10 years.
Complications:
Calling your health care provider:
Call for an appointment with your health care provider if symptoms indicate MPGN II.
Call for an appointment with your health care provider if symptoms worsen or new symptoms develop, including decreased urine output.
|
